Sota Akamine, Shingo Totoki, Taku Itami, Jun Yoneyama,
Abstract When a disaster strikes, one of the highest priorities is to save the lives of the victims. The proportion of victims that rescuers can save is strongly related to how quickly rescue efforts can begin. Therefore, early detection of disaster victims is very important. However, significant risks are involved in rescue operations immediately after a disaster. In fact, in the Great East Japan Earthquake, approximately 250 firefighters died while rescuing victims. Under such circumstances, rapid ...
Tópico(s): Video Surveillance and Tracking Methods
2022 - Springer Science+Business Media | Artificial Life and Robotics
Gouji Toyokawa, Kazuki Takada, Tatsuro Okamoto, Satoshi Kawanami, Yuka Kozuma, Taichi Matsubara, Naoki Haratake, Shinkichi Takamori, Takaki Akamine, Masakazu Katsura, Yuichi Yamada, Fumihiro Shoji, Shingo Baba, Takeshi Kamitani, Yoshinao Oda, Hiroshi Honda, Yoshihiko Maehara,
BackgroundProgrammed death ligand 1 (PD-L1) was reported to predict the response of immunotherapy; however, the association between PD-L1 expression and radiologic and pathologic features has yet to be elucidated.MethodsIn all, 292 patients with resected pathologic stage I adenocarcinoma were analyzed for PD-L1 expression by immunohistochemistry and evaluated to determine the association between PD-L1 expression and the radiologic/pathologic invasiveness. Specifically, the radiologic invasiveness ...
Tópico(s): Lung Cancer Diagnosis and Treatment
2017 - Elsevier BV | The Annals of Thoracic Surgery
Masateru Kawakubo, Hiroto Waki, Takashi Shirasaka, T. Kojima, Ryoji Mikayama, Hiroshi Hamasaki, Hiroshi Akamine, Toyoyuki Kato, Shingo Baba, Shin Ushiro, Kousei Ishigami,
Tópico(s): Anatomy and Medical Technology
2022 - Springer Science+Business Media | International Journal of Computer Assisted Radiology and Surgery
Satomi Akamine, Kazuki Nakamori, Svetlana A. Chechetka, Mari Banba, Yosuke Umehara, Hiroshi Kouchi, Katsura Izui, Shingo Hata,
A full-length cDNA for squalene synthase was isolated from Lotus japonicus, a model leguminous plant. The transcript was abundant in roots, symbiotic root nodules, and shoots, in that order. In situ hybridization revealed that the mRNA level is high in expanding root cells but low in dividing root tip ones. The transcript is also abundant in vascular bundles and the basal portions of mature nodules. L. japonicus squalene synthase has an unusual Asp residue near the active site, where mammalian enzymes ...
Tópico(s): Plant nutrient uptake and metabolism
2003 - Elsevier BV | Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
Kazuki Takada, Gouji Toyokawa, Tatsuro Okamoto, Shingo Baba, Yuka Kozuma, Taichi Matsubara, Naoki Haratake, Takaki Akamine, Shinkichi Takamori, Masakazu Katsura, Fumihiro Shoji, Hiroshi Honda, Yoshinao Oda, Yoshihiko Maehara,
Abstract Programmed cell death‐1 ( PD ‐1) and programmed cell death‐ligand 1 ( PD ‐L1) have been identified as novel targets of immunotherapy of lung cancer. In present study, we evaluated the metabolic characteristics of lung cancer by using 18 F‐fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F‐ FDG PET / CT ) with regard to PD ‐L1 protein expression. PD ‐L1 protein expression was evaluated by immunohistochemistry with the antibody clone SP 142 in 579 surgically resected primary lung ...
Tópico(s): Cancer, Hypoxia, and Metabolism
2017 - Wiley | Cancer Medicine
Akiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, Hiroyuki Akamine, Yosuke Onishi, Manato Yasuda, Yukiko Ozawa, Naoki Kawaguchi, Tomoya Kubota, Masanori Takahashi, Yasushi Suzuki, Genya Watanabe, Takashi Kimura, Takamichi Sugimoto, Makoto Samukawa, Naoya Minami, Masayuki Masuda, Shingo Konno, Yuriko Nagane, Kimiaki Utsugisawa,
Background Early fast-acting treatment (EFT) is the aggressive use of fast-acting therapies such as plasmapheresis, intravenous immunoglobulin and/or intravenous high-dose methylprednisolone (IVMP) from the early phases of treatment. EFT is reportedly beneficial for early achievement of minimal manifestations (MM) or better status with ≤5 mg/day prednisolone (MM5mg), a practical therapeutic target for myasthenia gravis (MG). Objective The current study aimed to clarify which specific EFT regimen is efficacious ...
Tópico(s): Peripheral Neuropathies and Disorders
2023 - BMJ | Journal of Neurology Neurosurgery & Psychiatry
Shigeaki Suzuki, Masayuki Masuda, Akiyuki Uzawa, Yuriko Nagane, Shingo Konno, Yasushi Suzuki, Tomoya Kubota, Takamichi Sugimoto, Makoto Samukawa, Genya Watanabe, Kei Ishizuchi, Hiroyuki Akamine, Yosuke Onishi, Kazuki Yoshizumi, Takafumi Uchi, Itaru Amino, Yuki Ueta, Naoya Minami, Naoki Kawaguchi, Takashi Kimura, Masanori Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa,
Abstract The primary purpose of the Japanese myasthenia gravis registry (JAMG‐R) has been to research and promote high‐quality medical care for MG patients in Japan. We reviewed the findings of surveys performed by JAMG‐R over an ~10‐y period. The first goal for favorable quality of life (QOL) is a status of minimal manifestations (MM) or better with an oral prednisolone (PSL) dose of 5 mg/d or less (MM‐5 mg). E arly and aggressive use of nonoral f ast‐acting t reatment together with low‐dose oral PSL ( ...
Tópico(s): Antifungal resistance and susceptibility
2022 - Wiley | Clinical and Experimental Neuroimmunology
Yoshiko Habuchi, Akiko Tanaka, Yuko Yasuda, Shuko Tanaka, Aki Akamine, Shingo Sasaki, Makiko Naka, Ai Uemiya,
話題提供者，司会者変更
Tópico(s): Deception detection and forensic psychology
2019 - The Japanese Psychological Association | The Proceedings of the Annual Convention of the Japanese Psychological Association
Yoshiko Habuchi, Ai Uemiya, Yuko Yasuda, Aki Akamine, Shingo Sasaki, Makiko Naka, Shuko Tanaka, Akiko Tanaka,
Tópico(s): Deception detection and forensic psychology
2019 - The Japanese Psychological Association | The Proceedings of the Annual Convention of the Japanese Psychological Association
Sota Akamine, Shingo TOTOKI, Taku Itami, Jun Yoneyama,
In recent years, the importance of autonomous mobile robots has been increasing in disaster situations．In this study，we developed a system that can measure the straight-line distance to obstacles in real time using a monocular camera and a line laser，and verified the effectiveness of the system using a crawler robot equipped with the system．The effectiveness of the proposed method is demonstrated by making a crawler robot equipped with a line laser and a camera move straight toward an obstacle, ...
Tópico(s): Robotics and Sensor-Based Localization
2022 - Japan Society Mechanical Engineers | The Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec)
Kiyohisa Kamimura, Masanori Nakajo, Tomohide Yoneyama, Yoshihiko Fukukura, Shingo Fujio, Yuko Goto, Takashi Iwanaga, Yuta Akamine, Takashi Yoshiura,
Tópico(s): Advanced Neuroimaging Techniques and Applications
2019 - Springer Science+Business Media | European Radiology
Daiki Tokuyasu, Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Takamichi Sugimoto, Kei Ishizuchi, Munenori Oyama, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Yasushi Suzuki, Naoki Kawaguchi, Naoya Minami, Takashi Kimura, Masanori Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa,
Abstract Objective Eculizumab and ravulizumab are complement protein C5 inhibitors, showing efficacy and tolerability for patients with anti‐acetylcholine receptor‐positive (AChR+) generalized myasthenia gravis (gMG) in phase 3 clinical trials and subsequent analyses. The purpose of the present study was to evaluate the clinical significance of eculizumab and switching to ravulizumab for refractory AChR+ gMG patients in the real‐world experience. Methods Among the database of Japan MG registry survey ...
Tópico(s): Antifungal resistance and susceptibility
2024 - Wiley | Annals of Clinical and Translational Neurology
Diana Agostini‐Vulaj, Justin Cates, Laura Bratton, Raul S. González, Diana Agostini, Tomoki Akamine, Nicolas Lanthier, Shingo Arakaki, Tatsuji Maeshiro, Kennosuke Karube, Mina Komuta, Ram Al-Sabti, Marcela Salomao, Rish K. Pai, Jerome Cheng, Maria Westerhoff, David Papke, Lei Zhao, Shaomin Hu, Nicole C. Panarelli, Katherine Boylan, John Hart, Manju Ambelil, Madhavi Rayapudi, Thomas D. Schiano, Maria Isabel Fiel, Ahmed Bakhshwin, Sindhu Shetty, Haiyan Lu, Michael Cruise, Keith Lai,
Tópico(s): Amoebic Infections and Treatments
2019 - Elsevier BV | Modern Pathology
Akiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, Hiroyuki Akamine, Yosuke Onishi, Manato Yasuda, Yukiko Ozawa, Naoki Kawaguchi, Tomoya Kubota, Masanori Takahashi, Yasushi Suzuki, Genya Watanabe, Takashi Kimura, Takamichi Sugimoto, Makoto Samukawa, Naoya Minami, Masayuki Masuda, Shingo Konno, Yuriko Nagane, Kimiaki Utsugisawa,
The efficacy of intravenous high-dose methylprednisolone (IVMP) in ocular myasthenia gravis (MG) has not been fully established. This study aimed to elucidate the effects of early intervention with IVMP for achieving the therapeutic targets (minimal manifestations [MM] or MM or better status with prednisolone ≤ 5 mg/day [MM5mg]) in ocular MG. In this observational study, we included a total of 1710 consecutive patients with MG enrolled in the Japan MG Registry in 2021. Of these, 204 patients with ocular ...
Tópico(s): Peripheral Neuropathies and Disorders
2023 - Springer Science+Business Media | Neurotherapeutics
Manato Yasuda, Akiyuki Uzawa, Satoshi Kuwabara, Shigeaki Suzuki, Hiroyuki Akamine, Yosuke Onishi, Yukiko Ozawa, Naoki Kawaguchi, Tomoya Kubota, Masanori Takahashi, Yasushi Suzuki, Genya Watanabe, Takashi Kimura, Takamichi Sugimoto, Makoto Samukawa, Naoya Minami, Masayuki Masuda, Shingo Konno, Yuriko Nagane, Kimiaki Utsugisawa,
This study included 51 patients with muscle-specific kinase antibody-positive myasthenia gravis (MuSK-MG) from a Japanese multicenter survey to examine clinical features and outcomes. Median onset age was 37 years and female predominance was observed. All patients developed generalized symptoms and almost all (50/51) patients had bulbar symptoms. About half of the patients met the criteria for refractory MG. The refractory group had a lower age of onset, higher severity scores, and higher maximum ...
Tópico(s): Parkinson's Disease and Spinal Disorders
2023 - Elsevier BV | Journal of Neuroimmunology
Oz M. Shapira, Orit Blumenfeld, Gil Bolotin, Frederick L. Grover, David M. Shahian, John M. Stulak, Ashraf Abou, El Ela, Francis D. Pagani, Juan Sánchez, Kevin W. Lobdell, Susan D. Moffatt‐Bruce, James I. Fann, Mustapha El Lakis, Stephen J. Kaplan, Michal Hubka, Kamran Mohiuddin, Donald E. Low, Juri Bassuner, David C. Rice, Mara B. Antonoff, Arlene M. Correa, Garrett L. Walsh, Ara Vaporciyan, Naveen Garg, Boris Sepesi, Stephen G. Swisher, Wayne Hofstetter, Jack A. Roth, Reza J. Mehran, Travis C. Geraci, Vanessa Baratta, John Young, Steven Milman, Annmarie L. Dunican, Richard G. Jones, Thomas Ng, Vivo Lung, Perfusion Rehabilitates, J. Hunter Mehaffey, Eric J. Charles, Ashish Sharma, Morgan Salmon, Dustin Money, Sarah Schubert, Mark H. Stoler, Curtis G. Tribble, Victor E. Laubach, Mark E. Roeser, Irving L. Kron, Laura Donahoe, Moira de Valence, Eshetu G. Atenafu, Waël C. Hanna, Thomas K. Waddell, Andrew J. Pierre, Kazuhiro Yasufuku, Marc de Perrot, Marcelo Cypel, Shaf Keshavjee, Gail Darling, Anna Bendzsak, Sjoerd A. de Beer, Martin Gritter, Justin De Jong, Ernst Van Heurn, Gouji Toyokawa, Kazuki Takada, Tatsuro Okamoto, Satoshi Kawanami, Yuka Kozuma, Taichi Matsubara, Naoki Haratake, Shinkichi Takamori, Takaki Akamine, Masakazu Katsura, Yuichi Yamada, Fumihiro Shoji, Shingo Baba, Takeshi Kamitani, Yoshinao Oda, Hiroshi Honda, Yoshihiko Maehara, Prashanth Vallabhajosyula, Laxminarayana Korutla, Andreas Habertheuer, Sanjana Reddy, Christian Schaufler, J. Lasky, Joshua M. Diamond, Edward Cantu, Chi‐Fu Jeffrey Yang, Derek Y. Chan, Paul J. Speicher, Brian C. Gulack, Betty C. Tong, Matthew G. Hartwig, Chris R. Kelsey, Thomas A. D’Amico, Mark Berry, David Harpole, Hajime Saito, Hayato Konno, Maiko Atari, Nobuyasu Kurihara, Satoshi Fujishima, Yusuke Sato, Satoru Motoyama, Yoshihiro Minamiya, M Fukui, Kazuya Takamochi, Shiaki Oh, Takeshi Matsunaga, Kazuhiro Suzuki, Katsutoshi Ando, Kenji Suzuki, Ping Yuan, Cao Jin-lin, Sha Huang, Chong Zhang, Feichao Bao, Yeji Hu, Wang Lv, Jian Hu, Julie A. Barta, Claudia I. Henschke, M Flores, Rowena Yip, David F. Yankelevitz, Charles Powell, Yi‐Dan Lin, Zhihui Li, Gang Li, Xiaolong Zhang, Hanyu Deng, Xiaoyan Yang, Lunxu Liu, Christian McNeely, Alan Zajarías, Randall Robbs, Stephen Markwell, Christina M. Vassileva, Robert P. Hawkins, Emily Downs, Lily E. Johnston, Clifford E. Fonner, Ravi K. Ghanta, Alan M. Speir, Jeffrey Rich, Mohammed Quader, Leora T. Yarboro, Gorav Ailawadi, Jiro Esaki, Bradley G. Leshnower, José Binongo, Yi Lasanajak, Laronica Mcpherson, Michael E. Halkos, Robert Guyton, Edward Chen, Hoda Javadikasgari, A. Marc Gillinov, Jay J. Idrees, Tomislav Meštrović, Rakesh M. Suri, Sajjad Raza, Penny L. Houghtaling, Lars G. Svensson, L Navia, Stephanie Mick, Milind Y. Desai, Joseph F. Sabik, Eugene H. Blackstone, Benjamin Sun, Timothy Dickinson, Eric A. Tesdahl, Donald S. Likosky, Christopher Wells, Samuel Weinstein, Gian Luca Martinelli, Attilio Cotroneo, Philippe Primo Caimmi, Gabriele Musica, David Barill, E. Stelian, Angelo Romano, Eugenio Novelli, L. Renzi, Marco Diena, Foeke J.H. Nauta, Kevin Ka‐Lun Lau, Christopher J. Arthurs, Kim A. Eagle, David Williams, Santi Trimarchi, Himanshu J. Patel, Carlos R. Figueroa, Gaku Uchino, Keiji Yunoki, Shigeru Hattori, Naoya Sakoda, Takuya Kawabata, Munehiro Saiki, Yasufumi Fujita, Kunikazu Hisamochi, Hideo Yoshida, Joseph Lamelas, Roy Williams, Maurice Mawad, Angelo LaPietra, Sven Lehmann, Anna L. Meyer, Thomas Schroeter, Madlen Uhlemann, Julia Fischer, Sergey Leontyev, Jens Garbade, David Holzhey, Martín Misfeld, Friedrich‐Wilhelm Mohr, Kendra J. Grubb, Jennifer Peterson, Lazaros Kochilas, Kirsti Catton, James Moller, Shaun P. Setty, E. B. Graham, Joshua Friedland-Little, Karen Uzark, Sunkyung Yu, Ray Lowery, Ranjit Aiyagari, Jennifer C. Hirsch‐Romano, Joshua J. Blinder, Ravi R. Thiagarajan, Kathryn Williams, Meena Nathan, John E. Mayer, Thomas J. Kulik, Akihiko Higashida, Takaya Hoashi, Koji Kagisaki, Masatoshi Shimada, Hideo Ohuchi, Isao Shiraishi, Hajime Ichikawa, Elizabeth H. Stephens, Dustin M. Walters, Amanda L. Eilers, Vakhtang Do, Andrew Tchantchaleishvili, Erin Goldstone, Amy Gillaspie, Damien Fiedler, Randolph H.L. Wong, P. H. F. Yu, Micky W.T. Kwok, Simon Kwoon‐Ho Chow, Jacky Y. K. Ho, Martin Underwood, Simon C.H. Yu, Makoto Hibino, Tomonobu Abe, Hideki Oshima, Yuji Narita, Masato Mutsuga, Kazuro Fujimoto, Yoshiyuki Tokuda, Koji Yamana, Taiyo Kuroda, Akihiko Usui, Mikael Barbu, Claes Nordborg, Andreas Martinsson, Christian Dworeck, Anders Jeppsson, Alexander A. Brescia, Steven F. Bolling, Jack Keenan, Konrad Rajab, David Armstrong, Zain Khalpey, Heidi Schubmehl, Huan Sun, Jessica Donington, Deane K. Smith, Eugene A. Grossi, Novel Surgical, Salah E. Altarabsheh, Salil V. Deo, M Alma'ayeh, Muhannad Jalookh, Ashraf Alshabatat, Yagthan M. Obeidat, Abeer M. Rababa’h, M Alazzam,
Elsevier BV
Akiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, Hiroyuki Akamine, Yosuke Onishi, Manato Yasuda, Yukiko Ozawa, Naoki Kawaguchi, Tomoya Kubota, Masanori Takahashi, Yasushi Suzuki, Genya Watanabe, Takashi Kimura, Takamichi Sugimoto, Makoto Samukawa, Naoya Minami, Masayuki Masuda, Shingo Konno, Yuriko Nagane, Kimiaki Utsugisawa,
Non-motor symptoms in myasthenia gravis (MG) are rarely confirmed. Although there are some small cohort studies, a large-systemic survey has not yet been performed.
Tópico(s): Autoimmune Neurological Disorders and Treatments
2024 - BioMed Central | BMC Neurology
Satomi Akamine, Mari Banba, Yosuke Umehara, Hiroshi Kouchi, Katsura Izui, Shingo Hata,
Tópico(s): Plant biochemistry and biosynthesis
2001 - Oxford University Press | Plant and Cell Physiology
Genya Watanabe, Yoshiki Takai, Yuriko Nagane, Tomoya Kubota, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Akiyuki Uzawa, Naoki Kawaguchi, Masayuki Masuda, Shingo Konno, Itaru Amino, Naoya Minami, Takashi Kimura, Makoto Samukawa, Takamichi Sugimoto, Yasushi Suzuki, Masanori Takahashi, Shigeaki Suzuki, Hiroyuki Murai, Masashi Aoki, Kimiaki Utsugisawa,
International consensus guidance and Japanese clinical guidelines for myasthenia gravis (MG) recommend achieving minimal manifestations or better status (MM-or-better) as the severity component of the treatment goal. However, the subjective nature of determining MM can result in ambiguity regarding this category in clinical practice and clinical trials. This study analyzed severity metrics in a large number of MG patients to propose criteria for MM-or-better. We utilized data obtained from 3800 MG ...
Tópico(s): Peripheral Neuropathies and Disorders
2024 - Frontiers Media | Frontiers in Immunology
Yoshiko Habuchi, Makiko Naka, Shuko Tanaka, Ai Uemiya, Shingo Sasaki, Akiko Tanaka, Yuko Yasuda, Aki Akamine,
Tópico(s): Deception detection and forensic psychology
2019 - The Japanese Psychological Association | The Proceedings of the Annual Convention of the Japanese Psychological Association
Takamichi Sugimoto, Shigeaki Suzuki, Akiyuki Uzawa, Takemori Yamawaki, Masayuki Masuda, Naoya Minami, Naoki Kawaguchi, Tomoya Kubota, Masanori Takahashi, Yasushi Suzuki, Genya Watanabe, Shingo Konno, Takashi Kimura, Makoto Samukawa, Kei Ishizuchi, Hiroyuki Akamine, Yosuke Onishi, Manato Yasuda, Yuriko Nagane, Hirofumi Maruyama, Hiroyuki Murai, Kimiaki Utsugisawa,
Tópico(s): Coagulation, Bradykinin, Polyphosphates, and Angioedema
2024 - Elsevier BV | Journal of the Neurological Sciences
Manato Yasuda, Akiyuki Uzawa, Satoshi Kuwabara, Shigeaki Suzuki, Hiroyuki Akamine, Yosuke Onishi, Yukiko Ozawa, Naoki Kawaguchi, Tomoya Kubota, Masanori Takahashi, Yasushi Suzuki, Genya Watanabe, Takashi Kimura, Takamichi Sugimoto, Makoto Samukawa, Naoya Minami, Masayuki Masuda, Shingo Konno, Yuriko Nagane, Kimiaki Utsugisawa,
Tópico(s): Parkinson's Disease and Spinal Disorders
2024 - Elsevier BV | Journal of Neuroimmunology
Kenichi Nishimura, Takashi Ishikawa, Nami Okamoto, Keiji Akamine, Natsumi Inoue, Hitoshi Irabu, Kentaro Kato, Hiroshi Keino, Masayo Kojima, Hiroshi Kubo, Kazuichi Maruyama, Mao Mizuta, Kosuke Shabana, Masaki Shimizu, Yuko Sugita, Yukiko Takakuwa, Satoshi Takanashi, Hiroshi Takase, Hiroaki Umebayashi, Natsuka Umezawa, Shingo Yamanishi, Kazuko Yamazaki, Masato Yashiro, Takahiro Yasumi, M. Mori,
ABSTRACT Objectives This systematic review assessed the efficacy and safety of abatacept in patients with systemic juvenile idiopathic arthritis (JIA). Methods Studies published between 2000 and 2021 were searched using PubMed, Embase, Cochrane, Ichushi-Web, and clinical trial registries. The risk of bias was assessed according to the manual for development clinical practice guidelines by Minds, a project to promote evidence-based medicine in Japan. Results Seven observational studies were included. ...
Tópico(s): Inflammasome and immune disorders
2024 - Oxford University Press | Modern Rheumatology
Takashi Ishikawa, Kenichi Nishimura, Nami Okamoto, Keiji Akamine, Natsumi Inoue, Hitoshi Irabu, Kentaro Kato, Hiroshi Keino, Masayo Kojima, Hiroshi Kubo, Kazuichi Maruyama, Mao Mizuta, Kosuke Shabana, Masaki Shimizu, Yuko Sugita, Yukiko Takakuwa, Satoshi Takanashi, Hiroshi Takase, Hiroaki Umebayashi, Natsuka Umezawa, Shingo Yamanishi, Kazuko Yamazaki, Masato Yashiro, Takahiro Yasumi, Masaaki Mori,
ABSTRACT Objectives This systematic review assessed the efficacy and safety of tumor necrosis factor (TNF) inhibitors in patients with systemic juvenile idiopathic arthritis (JIA). Methods Studies were searched using PubMed, Embase, Cochrane, Ichushi-Web, and clinical trial registries (from 2000 to 2021). The risk of bias was assessed using the Cochrane Risk of Bias version 2 for randomized controlled trials (RCTs) and the manual of Minds for observational studies. Results One RCT and 22 observational ...
Tópico(s): Adolescent and Pediatric Healthcare
2024 - Oxford University Press | Modern Rheumatology